PURPOSE: HLA protein receptors play a key role in cellular immunity. They bind intracellular peptides and display them for recognition by T-cell lymphocytes. Because T-cell activation is partially driven by structural features of these peptide-HLA complexes, their structural modeling and analysis are becoming central components of cancer immunotherapy projects. Unfortunately, this kind of analysis is limited by the small number of experimentally determined structures of peptide-HLA complexes. Overcoming this limitation requires developing novel computational methods to model and analyze peptide-HLA structures. METHODS: Here we describe a new platform for the structural modeling and analysis of peptide-HLA complexes, called HLA-Arena, which we have implemented using Jupyter Notebook and Docker. It is a customizable environment that facilitates the use of computational tools, such as APE-Gen and DINC, which we have previously applied to peptide-HLA complexes. By integrating other commonly used tools, such as MODELLER and MHCflurry, this environment includes support for diverse tasks in structural modeling, analysis, and visualization. RESULTS: To illustrate the capabilities of HLA-Arena, we describe 3 example workflows applied to peptide-HLA complexes. Leveraging the strengths of our tools, DINC and APE-Gen, the first 2 workflows show how to perform geometry prediction for peptide-HLA complexes and structure-based binding prediction, respectively. The third workflow presents an example of large-scale virtual screening of peptides for multiple HLA alleles. CONCLUSION: These workflows illustrate the potential benefits of HLA-Arena for the structural modeling and analysis of peptide-HLA complexes. Because HLA-Arena can easily be integrated within larger computational pipelines, we expect its potential impact to vastly increase. For instance, it could be used to conduct structural analyses for personalized cancer immunotherapy, neoantigen discovery, or vaccine development.
PURPOSE: HLA protein receptors play a key role in cellular immunity. They bind intracellular peptides and display them for recognition by T-cell lymphocytes. Because T-cell activation is partially driven by structural features of these peptide-HLA complexes, their structural modeling and analysis are becoming central components of cancer immunotherapy projects. Unfortunately, this kind of analysis is limited by the small number of experimentally determined structures of peptide-HLA complexes. Overcoming this limitation requires developing novel computational methods to model and analyze peptide-HLA structures. METHODS: Here we describe a new platform for the structural modeling and analysis of peptide-HLA complexes, called HLA-Arena, which we have implemented using Jupyter Notebook and Docker. It is a customizable environment that facilitates the use of computational tools, such as APE-Gen and DINC, which we have previously applied to peptide-HLA complexes. By integrating other commonly used tools, such as MODELLER and MHCflurry, this environment includes support for diverse tasks in structural modeling, analysis, and visualization. RESULTS: To illustrate the capabilities of HLA-Arena, we describe 3 example workflows applied to peptide-HLA complexes. Leveraging the strengths of our tools, DINC and APE-Gen, the first 2 workflows show how to perform geometry prediction for peptide-HLA complexes and structure-based binding prediction, respectively. The third workflow presents an example of large-scale virtual screening of peptides for multiple HLA alleles. CONCLUSION: These workflows illustrate the potential benefits of HLA-Arena for the structural modeling and analysis of peptide-HLA complexes. Because HLA-Arena can easily be integrated within larger computational pipelines, we expect its potential impact to vastly increase. For instance, it could be used to conduct structural analyses for personalized cancer immunotherapy, neoantigen discovery, or vaccine development.
Authors: H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne Journal: Nucleic Acids Res Date: 2000-01-01 Impact factor: 16.971
Authors: Alexander S Rose; Anthony R Bradley; Yana Valasatava; Jose M Duarte; Andreas Prlic; Peter W Rose Journal: Bioinformatics Date: 2018-11-01 Impact factor: 6.937
Authors: Dinler A Antunes; Jayvee R Abella; Didier Devaurs; Maurício M Rigo; Lydia E Kavraki Journal: Curr Top Med Chem Date: 2018 Impact factor: 3.295
Authors: Gregory Lizée; Willem W Overwijk; Laszlo Radvanyi; Jianjun Gao; Padmanee Sharma; Patrick Hwu Journal: Annu Rev Med Date: 2012-10-22 Impact factor: 13.739
Authors: Peter Eastman; Jason Swails; John D Chodera; Robert T McGibbon; Yutong Zhao; Kyle A Beauchamp; Lee-Ping Wang; Andrew C Simmonett; Matthew P Harrigan; Chaya D Stern; Rafal P Wiewiora; Bernard R Brooks; Vijay S Pande Journal: PLoS Comput Biol Date: 2017-07-26 Impact factor: 4.475
Authors: Marek Wieczorek; Jana Sticht; Sebastian Stolzenberg; Sebastian Günther; Christoph Wehmeyer; Zeina El Habre; Miguel Álvaro-Benito; Frank Noé; Christian Freund Journal: Nat Commun Date: 2016-11-09 Impact factor: 14.919
Authors: Dario F Marzella; Farzaneh M Parizi; Derek van Tilborg; Nicolas Renaud; Daan Sybrandi; Rafaella Buzatu; Daniel T Rademaker; Peter A C 't Hoen; Li C Xue Journal: Front Immunol Date: 2022-05-10 Impact factor: 8.786
Authors: Renata Fioravanti Tarabini; Mauricio Menegatti Rigo; André Faustino Fonseca; Felipe Rubin; Rafael Bellé; Lydia E Kavraki; Tiago Coelho Ferreto; Dinler Amaral Antunes; Ana Paula Duarte de Souza Journal: Front Immunol Date: 2022-01-13 Impact factor: 7.561
Authors: Thais Arns; Dinler A Antunes; Jayvee R Abella; Maurício M Rigo; Lydia E Kavraki; Silvana Giuliatti; Eduardo A Donadi Journal: Front Immunol Date: 2020-11-06 Impact factor: 7.561